Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Obici

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Journal of the Neurological Sciences|November 16, 2025
Long-term follow-up with magnetic resonance neurography in a patient with hereditary transthyretin amyloidosis treated with inotersenRoberto Gasparotti, Alessandro Salvalaggio, Roberta Mussinelli, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 21, 2002
Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosisEloisa Arbustini, Laura Verga, Monica Concardi, et al.
Clinical and Experimental Rheumatology|April 5, 2017
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Luca Cantarini, Valentina Pucino, Antonio Vitale, et al.
Blood|July 4, 2007
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosisGiovanni Palladini, Paola Russo, Mario Nuvolone, et al.
Neurodegenerative Disease Management|November 28, 2018
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosisArnt V Kristen, Senda Ajroud-Driss, Isabel Conceição, et al.
Journal of Lipid Research|January 7, 2021
Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol effluxOktawia Nilsson, Mikaela Lindvall, Laura Obici, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 17, 2006
Structure, function and amyloidogenic propensity of apolipoprotein A-ILaura Obici, Guido Franceschini, Laura Calabresi, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib, and dexamethasoneGiovanni Palladini, Andrea Foli, Paola Russo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 25, 2019
Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progressionIsabel Conceição, Teresa Coelho, Claudio Rapezzi, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesisFrancesca Brambilla, Francesca Lavatelli, Veronica Valentini, et al.
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Journal of the Neurological Sciences|November 16, 2025
Long-term follow-up with magnetic resonance neurography in a patient with hereditary transthyretin amyloidosis treated with inotersenRoberto Gasparotti, Alessandro Salvalaggio, Roberta Mussinelli, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 21, 2002
Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosisEloisa Arbustini, Laura Verga, Monica Concardi, et al.
Clinical and Experimental Rheumatology|April 5, 2017
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS)Luca Cantarini, Valentina Pucino, Antonio Vitale, et al.
Blood|July 4, 2007
Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosisGiovanni Palladini, Paola Russo, Mario Nuvolone, et al.
Neurodegenerative Disease Management|November 28, 2018
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosisArnt V Kristen, Senda Ajroud-Driss, Isabel Conceição, et al.
Journal of Lipid Research|January 7, 2021
Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol effluxOktawia Nilsson, Mikaela Lindvall, Laura Obici, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 17, 2006
Structure, function and amyloidogenic propensity of apolipoprotein A-ILaura Obici, Guido Franceschini, Laura Calabresi, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib, and dexamethasoneGiovanni Palladini, Andrea Foli, Paola Russo, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 25, 2019
Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progressionIsabel Conceição, Teresa Coelho, Claudio Rapezzi, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesisFrancesca Brambilla, Francesca Lavatelli, Veronica Valentini, et al.
Pageof 21